NEW YORK (TheStreet) -- CHANGE IN RATINGS

Adobe Systems ( ADBE) numbers boosted at Jefferies through 2010. Headcount reduction should boost margins. Hold rating and new $40 price target.

Adobe Systems ( ADBE) downgraded at Oppenheimer from Outperform to Perform. Valuation call, as the selling environment remains challenging.

Allegheny Energy ( AYE) downgraded at Citigroup from Buy to Hold. $23 price target. Estimates also cut, to reflect new details about the merchant supply business.

Dime Communications ( DCOM) upgraded at Barclays to Overweight from Equal Weight. Price target increased to $15 from $12. 2009 and 2010 EPS estimates raised to $0.93 and $1.15, respectively.

Education Management ( EDMC) initiated at BofA/Merrill with a Buy rating and $26 price target. 2010 and 2011 EPS estimates set at $1.10 and $1.33, respectively.

Education Management ( EDMC) initiated at Barclays with an Overweight rating and $27 price target. 2010 and 2011 EPS estimates set at $1.12 and $1.43, respectively.

Fluor ( FLR) upgraded at Citigroup from Sell to Hold. Company had a mixed quarter, but risks are already being priced into the stock. $50 price target.

FPL Group ( FPL) upgraded at Citigroup from Hold to Buy. $58 price target. Stock looks attractive ahead of its next rate case in Florida.

Hewitt Associates ( HEW) upgraded at Deutsche Bank. Rating raised to Buy from Hold. Price target raised to $55 from $35. 2009 EPS estimates raised to $2.67 from $2.60.

Microchip Tech ( MCHP) upgraded at Goldman from Sell to Neutral. $24 price target. Valuation call, as the company is poised to gain market share in the near term.

Myriad Genetics ( MYGN) upgraded at Morgan Joseph from Sell to Hold. Stock is now pricing in lower growth expectations.

Smithfield Foods ( SFD) upgraded at Deutsche Bank. Rating raised to Buy from Hold. Price target raised to $20 from $12. Fiscal 2010 EPS estimates raised to -$0.27 from -$0.88.

Talecris Biotherapeutics ( TLCR) initiated at Barclays with an Equal Weight rating and $24 price target. 2009 and 2010 EPS estimates set at $1.42 and $1.60, respectively.

Talecris Bio ( TLCR) estimates raised at Morgan Stanley through 2010. Visibility is improving and the company is realizing lower R&D sales. Overweight rating and $24 price target.

Toll Brothers ( TOL) upgraded at Wells from Market Perform to Outperform. Company has strong order growth and should be profitable in 2010.

Tyson Foods ( TSN) downgraded at JP Morgan. Rating lowered to Neutral from Overweight. Price target lowered to $12 from $14. Maintains 2009 EPS estimates of $0.33.

Webster Financial ( WB) upgraded at Barclays to Overweight from Equal Weight on valuation. 2009 and 2010 EPS estimates set at -$1.71 and $0.10, respectively. Maintain $15 price target.

Zions Bancorp ( ZION) downgraded at Morgan Keegan from Outperform to Market Perform. Company likely to be hit by ongoing regulatory pressure for banks to have higher capital reserves.

STOCK COMMENTS / EPS CHANGES

Baker Hughes ( BHI) price target raised at Barclays. BHI shares now seen reaching $41, up from $33. 2009 EPS estimate lowered to $1.83 from $1.99, 2010 lifted to $1.75 from $1.60. Maintain Equal Weight rating.

Chesapeake Energy ( CHK) price target higher at Barclays. CHK shares now seen reaching $32, up from $30. 2009 EPS estimate raised to $2.55 from $2.50, 2010 cut to $2.35 from $2.75. Maintain Overweight rating.

Salesforce.com ( CRM) price target higher at BofA/Merrill to $72 as booking should re-accelerate. 2010 and 2011 EPS estimates set at $1.11 and $1.27, respectively.

Cytec ( CYR) added to Conviction Sell list at Goldman. Valuation call, as the company has high exposure to the late-cycle aerospace industry. $31 price target.

Express Scripts ( ESRX) price target boosted at Barclays to $95 from $92. 2009 and 2010 EPS estimates maintained at $3.45 and $4.65, respectively. Reiterate Equal Weight rating.

Gilead Sciences ( GILD) numbers raised at Goldman through 2011. Growth in Europe is set to rise. Neutral rating and new $53 price target.

Gamestop ( GME) cut from Conviction Buy list at Goldman. Estimates also lowered to reflect weaker video game industry sales. $29 price target.

Hewitt Assoc. ( HEW) estimates raised at Goldman through 2012. Company guided to improving margins. Sell rating and $36 price target.

Medco Health Solutions ( MHS) price target lifted at Barclays by two dollars to $68. Maintain 2009 and 2010 EPS estimates at $2.82 and $3.35, respectively. Reiterate Overweight rating.

Newell Rubbermaid ( NWL) estimates cut at Goldman through 2011. Convertible bonds will be dilutive to earnings. Neutral rating and $16 price target.

O'Reilly Automotive ( ORLY) numbers boosted at Goldman. Shares of ORLY now seen reaching $45. Estimates also raised, to reflect a ramp in the CSK integration. Neutral rating.

Priceline.com ( PCLN) estimates increased at Morgan Stanley through 2011. Company is seeing higher bookings, especially overseas. Equal-weight rating.

Teco Energy ( TE) numbers raised at Morgan Stanley Shares of TE now seen reaching $16.25. Estimates also increased, to reflect improving coal margins. Overweight rating.

Tesoro ( TSO) price target cut at Barclays by a dollar to $16. 2009 and 2010 EPS estimates lowered to -$0.05 and $1.20, respectively. Maintain Equal Weight rating.

TechTarget ( TTGT) estimates higher at Barclays. TTGT 2009 EPS estimate up by a penny to $0.21, 2010 introduced at $0.30. Reiterate Equal Weight rating and $5 price target.

Tyco International ( TYC) 2010 estimate cut at Barclays by 5 cents to $2.50 after conservative guidance by the company. Maintain Equal Weight rating and $43 price target.

Tyco ( TYC) estimates, target raised at UBS. Estimates were increased through 2010. Target also boosted, to reflect the potential for acquisitions and/or a stock buyback. Buy rating.

Weyerhaeuser ( WY) estimates higher at Barclays. 2009 EPS estimate tweaked to -$2.05 from -$2.06, 2010 raised by a dime to -$0.45. Reiterate Overweight rating and $55 price target.

This article was written by a staff member of TheStreet.com.

More from Stocks

The Best Investment Advice? Stay Diversified

The Best Investment Advice? Stay Diversified

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Listen: Should You Buy Cisco Now?

Listen: Should You Buy Cisco Now?

Amazon Could Devastate Walgreens and Rite Aid by Getting Into Pharmacy Business

Amazon Could Devastate Walgreens and Rite Aid by Getting Into Pharmacy Business

Amazon's Assault on Grocery Stores Will Have a Profound Impact on Many

Amazon's Assault on Grocery Stores Will Have a Profound Impact on Many